Are you at risk of a genetic disease? Guidelines for testing should be updated, experts say

3:00 PM

Author | Kelly Malcom

Close up of woman's mouth as cheek swab is performed, with Q tip held in a green medical gloved hand.
Photo credit: Getty Images

Would you want to know if you had a gene change for a fatal hereditary neurological condition that causes motor, cognitive and psychiatric symptoms in your mid 30s/early 40s or if you are at higher risk of developing Alzheimer’s disease?  

 

Individuals who have a parent with Huntington’s disease face a 50 percent risk of developing the disease as well. While predictive genetic testing for Huntington's disease has been available for decades, studies show that only 10 to 25 percent of those at risk get tested. 

 

“The Huntington’s disease predictive genetic testing protocol has been in existence for more than 40 years,” says Wendy Uhlmann, M.S., a licensed genetic counselor and researcher at Michigan Medicine who is calling for a much-needed update to guidance in light of changes to health care delivery, new legislation and advances in genetic testing.   

 

The last guidance updates were in 2013 by clinicians and by the Huntington’s Disease Society of America in 2016. For late-onset Alzheimer’s disease, recommendations for genetic testing were last issued in 2011. 

 

Updates needed

In an article in the Journal of Genetic Counseling and Commentary in Frontiers in Dementia, Uhlmann and her colleagues review several significant developments since the last updates and offer practice recommendations and interim guidance, including discouraging direct to consumer testing for adult-onset neurological disorders like Huntington’s and Alzheimer’s diseases. 

 

Additional suggestions include: 

 

Changes to Healthcare Delivery: “The Huntington’s disease testing protocol was based on research protocols and developed at a time when genetic counselors were few in number,” shares Uhlmann.  

Previous guidance recommended a multidisciplinary team of practitioners, requiring multiple appointments. Uhlmann and the authors note the significant growth of the genetic counselor workforce with licensure in many states and the fact that genetic counselors independently see patients for predictive genetic counseling and testing. 

The testing protocol also stipulated in-person visits and a blood sample for genetic testing. Updates need to incorporate virtual visits and home collection options of saliva and cheek swab samples. 

 

Screening Calls: Uhlmann said another protocol update is needed for the recommendation that genetic counselors call patients prior to scheduling an appointment to explain the testing process and to discuss having desired insurance coverage (e.g., life) prior to testing in addition to obtaining an abbreviated family history and requesting records.  A follow-up call within one week was stipulated after receiving results. 

 

These recommendations are generally no longer routinely feasible given demands on genetic counselors’ time with higher patient volumes, increased genetic testing and billing requirements, said Uhlmann.  

 

Alternatives for providing pre-visit information are provided by the authors along with the recommendations to make post-result calls optional and less specific on timing.  

 

Mental Health:  The 2016 Huntington’s testing guidance advised that patients’ mental health be assessed for depression, anxiety and suicidality prior to testing. The authors note that research has shown that generally patients have few adverse mental health outcomes following testing and so a therapist assessment should be offered but not required unless there is concern the patient is at high risk for adverse psychological outcomes. 

 

Changes to Health Records: How we handle health records has changed, said Uhlmann. Previously, there were paper charts and therefore patients concerned about stigma or discrimination based on family history of Huntington’s could stipulate who amongst their care team had access to their records. Guidance needs to be updated to incorporate the widespread use of electronic health records and the fact that clinicians caring for patients have unrestricted access to chart information. 

  

Additionally, the 21st Century Cures Act, instituted in the U.S. in 2021, made medical test results readily available to patients, with results viewable in their portal even before review by a clinician. 

  

“Now when I counsel patients, I say, ‘even though test results are available, please do not view until we see you’,” said Uhlmann. Ready access to test results and the recommendation to delay viewing should be added to the guidance, she said. 

 

Reproductive Options: As access to abortion and potential IVF changes throughout the country, the authors suggest updating genetic testing protocols to note that changing legislation could potentially impact reproductive options and management of a pregnancy. 

 

Why update now? 

“The Huntington’s disease genetic testing protocol has been a model for other autosomal dominant conditions, including ALS, ataxias, frontotemporal dementia and early onset Alzheimer’s disease and has been adapted for hereditary cancers and other late-onset genetic conditions. Therefore, the need to update extends beyond Huntington’s disease,” says Uhlmann. 

 

Uhlmann and colleagues also recently wrote a commentary calling for an update on guidance for late-onset Alzheimer’s disease genetic testing and included key educational content to provide to patients.  

 

The APOE ε4 allele is the strongest risk factor for late-onset Alzheimer’s disease and testing is recommended in symptomatic individuals before prescribing anti-amyloid therapies because of increased risk for significant adverse side effects.  

 

When an APOE ε4 allele is identified, this means that children and siblings will have a 50 percent risk to have the ε4 allele. Currently, APOE testing is not clinically available to asymptomatic individuals which leaves interested individuals with direct-to-consumer testing without clinician involvement.  

 

According to Uhlmann and colleagues, “Though historically, APOE testing has not been recommended for asymptomatic individuals, we believe it is time to reconsider for individuals who have a first-degree affected relative and/or known APOE ε4 in the family.” 

 

 “Overall, the results from predictive genetic testing can be informative for life decisions, potentially impact care and are needed for determining eligibility for research and clinical trials.  As advances are made with gene-based therapies, at-risk individuals are going to want to have genetic testing to get access to therapy in a timely manner, so we need this process to be updated and more streamlined.” 

Additional authors: Jill S. Goldman, Jamie C. Fong, Weiyi Mu, Laynie Dratch, Amanda K. Chan  

 

Papers cited: “40+ years of the Huntington disease predictive genetic testing 

protocol: Recommendations for an update.” Journal of Genetic Testing, DOI: 10.1002/jgc4.70226. 

 

“Now is the time: the need to update guidance to expand access to APOE genetic testing,” Frontiers in Dementia. DOI: 10.3389/frdem.2026.1808512. 

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week. 

 

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  

 


More Articles About:

genetic counseling Health Care Delivery, Policy and Economics Lab Tests Neurological (Brain) Conditions Wellness and Prevention Alzheimer's Disease
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Wendy R. Uhlmann

Wendy Uhlmann, MS, LCGC

Clinical Professor

Related

Health Lab

Older Adults Have High Interest in Genetic Testing — and Some Reservations

More than 1 in 10 people ages 50 to 64 have had genetic tests ordered by a doctor or ordered them directly, a new survey finds. Others say they’re interested, but many have concerns.
woman on table with doctor talking to her
Health Lab

Engaging Huntington disease patients in research

Huntington disease research can be challenging as it is difficult for patients to get to clinical research sites. This new device brings the research mechanisms to them with the ability to complete studies from home.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Man sits in a medical exam room looking at caregiver whose back is to camera and looks toward a computer screen.
Health Lab

Updated prostate cancer screening guidelines emphasize benefits of early detection

New guidelines for prostate cancer screening focus on early detection and individual risk.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Small Pauses, Bigger Impact: Mindfulness in Action

What if well-being was built into the places where we live, learn and work? In this episode, Dr. Elizabeth Harry, is joined by three guests: recent past AMA president Dr. Bobby Mukkamala, who is board-certified in otolaryngology (head & neck surgery); Lauren Holaly-Zembo, CEO of the Crim Fitness Foundation; and Dr. Lisa Sancrant, Assistant Vice Chancellor for Health and Well-Being at UM-Flint, about how Flint, Michigan, is making mindfulness a community-wide priority. From classrooms to workplaces, they explore how small, accessible practices can support mental health, reduce stress, strengthen organizational cultures and help create healthier, more compassionate communities.
Young boy in purple t-shirt sits smiling in the grass on a sunny day.
Health Lab

From 20 seizures a day to more time for play: How personalized epilepsy care helped young patient

Advanced genetic testing and a detailed diagnosis revealed infant’s rare epilepsy, leading to a non-conventional therapy.
Medicaid magnifying glass
Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation
David Diebold smiles as he rings the bell at the end of the HURT100.
Philanthropy News

Going the extra 100 miles

U-M Medical School student runs the HURT100 ultramarathon to raise funds for the Michigan Alzheimer's Disease Center and the Alzheimer's Association.
Elderly man stands outside in a snowy neighborhood. He is holding a white mug of coffee in his right hand and has his left hand in a coat pocket. He is staring ahead, presumably taking in the snowy scene around him.
Health Lab

Small daily activities may help ease dementia caregivers’ stress

University of Michigan research suggests engaging in positive activities can improve the mood and physical wellbeing of Alzheimer’s disease or related dementia caregivers.